Pathology of Recurrence of Non-Neoplastic Disease After Liver Transplantation

Transplantation of the Liver

Volumn , Issue , 2005, Pages 1129-1148

  Lassman, Charles R ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Hepatobiliary Pathology   (United States)

^c Arkana Laboratories   (United States)

^d UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956338047     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0118-2.50075-6     Document Type: Chapter

References (140)

1. M Knoop, R Lusebrink, JM Langrehr, et al. (1994) Incidence and clinical relevance of recurrent hepatitis C infection after orthotopic liver transplantation. Transpl Int 7(Suppl 1), S221-S223.
2. P Martin, SJ Munoz, AM Di Biscegli, et al. (1991) Recurrence of hepatitis C virus infection after orthotopic liver transplantation. Hepatology 13 719-721.
3. C Feray, D Samuel, V Thiers, et al. (1992) Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 89 1361-1365.
4. TL Wright, E Donegan, HH Hsu, et al. (1992) Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 103 317-322.
5. NL Ascher, JR Lake, J Emond and J Roberts (1994) Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology 20(1 Pt 2), 24S-27S.
6. R Sallie, AT Cohen, CJ Tibbs, et al. (1994) Recurrence of hepatitis C following orthotopic liver transplantation: A polymerase chain reaction and histological study. J Hepatol 21 536-542.
7. V Konig, J Bauditz, H Lobeck, et al. (1992) Hepatitis C virus reinfection in allografts after orthotopic liver transplantation. Hepatology 16 1137-1143.
8. LD Ferrell, TL Wright, J Roberts, et al. (1992) Hepatitis C viral infection in liver transplant recipients. Hepatology 16 865-876.
9. KH Boker, G Dalley, MJ Bahr, et al. (1997) Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 25 203-210.
10. ML Shiffman, MJ Contos, VA Luketic, et al. (1994) Biochemical and histologic evaluation of recurrent hepatitis C following orthotopic liver transplantation. Transplantation 57 526-532.
11. R Mateo, A Demetris, E Sico, et al. (1993) Early detection of de novo hepatitis C infection in patients after liver transplantation by reverse transcriptase polymerase chain reaction. Surgery 114 442-448.
12. J Gugenheim, E Baldini, D Mazza, et al. (1994) Recurrence of hepatitis C virus after liver transplantation. Transpl Int 7(Suppl 1), S224-S226.
13. C Lumbreras, R Delgado, A Fuertes, et al. (1994) Clinical significance of hepatitis C virus (HCV) infection in liver transplant recipients. Role of serology and HCV RNA detection. Dig Dis Sci 39 965-969.
14. V Vargas, P Comas, L Castells, et al. (1994) Incidence and outcome of hepatitis C virus infection after liver transplantation. Transpl Int 7(Suppl 1), S216-S220.
15. T Fukumoto, T Berg, Y Ku, et al. (1996) Viral dynamics of hepatitis C early after orthotopic liver transplantation: Evidence for rapid turnover of serum virions. Hepatology 24 1351-1354.
16. JK Greenson, SM Svoboda-Newman, RM Merion and TS Frank (1996) Histologic progression of recurrent hepatitis C in liver transplant allografts. Am J Surg Pathol 20 731-738.
17. M Guido, S Fagiuoli, G Tessari, et al. (2002) Histology predicts cirrhotic evolution of post transplant hepatitis C. Gut 50 697-700.
18. PA Sheiner, ME Schwartz, E Mor, et al. (1995) Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 21 30-34.
19. H Sugo, GA Balderson, DH Crawford, et al. (2003) The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation. Surg Today 33 421-425.
20. MF Abdelmalek, RJ Firpi, C Soldevila-Pico, et al. (2004) Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Liver Transpl 10 199-207.
21. J Ahmad, SF Dodson, AJ Demetris, et al. (2001) Recurrent hepatitis C after liver transplantation: A nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin. Liver Transpl 7 863-869.
22. A Ahmed and EB Keeffe (2001) Hepatitis C virus and liver transplantation. Clin Liver Dis 5 1073-1090.
23. AB Alberti, LS Belli, A Airoldi, et al. (2001) Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: A pragmatic study. Liver Transpl 7 870-876.
24. P Andreone, A Gramenzi, C Cursaro, et al. (2001) Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: Results of a pilot study. Dig Liver Dis 33 693-697.
25. M Berenguer and TL Wright (1999) Treatment strategies for recurrent hepatitis C after liver transplantation. Clin Liver Dis 3 883-899.
26. T Bizollon, C Ducerf and C Trepo (1995) New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin. J Hepatol 23(Suppl 2), 22-25.
27. T Bizollon, SN Ahmed, S Radenne, et al. (2003) Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence. Gut 52 283-287.
28. RC Dickson, SH Caldwell, MB Ishitani, et al. (1996) Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation. Transplantation 61 701-705.
29. L Baiocchi, G Tisone, G Palmieri, et al. (1998) Hepatic steatosis: A specific sign of hepatitis C reinfection after liver transplantation. Liver Transpl Surg 4 441-447.
30. C Feray, M Gigou, D Samuel, et al. (1994) The course of hepatitis C virus infection after liver tranaplantation. Hepatology 20 1137-1143.
31. Banff schema for grading liver allograft rejection (1997) An international consensus document. Hepatology 25 658-663.
32. K Ishak, A Baptista, L Bianchi, et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22 696-699.
33. KP Batts and J Ludwig (1995) Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19 1409-1417.
34. VJ Desmet, M Gerber, JH Hoofnagel, et al. (1994) Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19 1513-1520.
35. RG Knodell, KG Ishak, WC Black, et al. (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1 431-435.
36. W Tillery, J Demetris, D Watkins, et al. (1989) Pathologic recognition of preservation injury in hepatic allografts with six months follow-up. Transplant Proc 21 1330-1331.
37. KL Aardema, RE Nakhleh, LK Terry, et al. (1999) Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants. Mod Pathol 12 1043-1049.
38. YN Park, P Boros, DY Zhang, et al. (2000) Serum hepatitis C virus RNA levels and histologic findings in liver allografts with early recurrent hepatitis C. Arch Pathol Lab Med 124 1623-1627.
39. R Sreekumar, A Gonzalez-Koch, Y Maor-Kendler, et al. (2000) Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Hepatology 32 1125-1130.
40. GJ Nuovo, A Holly, P Wakely Jr and W Frankel (2002) Correlation of histology, viral load, and in situ viral detection in hepatic biopsies from patients with liver transplants secondary to hepatitis C infection. Hum Pathol 33 277-284.
41. AJ Demetris, B Eghtesad, A Marcos, et al. (2004) Recurrent hepatitis C in liver allografts: Prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol 28 658-669.
42. MC Shuhart, MP Bronner, DR Gretch, et al. (1997) Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology 26 1646-1652.
43. KB Chopra, AJ Demetris, K Blakolmer, et al. (2003) Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation. Transplantation 76 1487-1491.
44. G Testa, JS Crippin, GJ Netto, et al. (2000) Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients. Liver Transpl 6 553-561.
45. A Demetris, D Adams, C Bellamy, et al. (2000) Update of the International Banff Schema for Liver Allograft Rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection. An international panel. Hepatology 31 792-799.
46. N Walker, R Apel, P Kerlin, et al. (1993) Hepatitis B virus infection in liver allografts. Am J Surg Pathol 17 666-677.
47. CM Lo, ST Cheung, IO Ng, et al. (2004) Fibrosing cholestatic hepatitis secondary to precore/core promoter hepatitis B variant with lamivudine resistance: Successful retransplantation with combination adefovir dipivoxil and hepatitis B immunoglobulin. Liver Transpl 10 557-563.
48. S Beckebaum, M Malago, O Dirsch, et al. (2003) Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation. Clin Transplant 17 554-559.
49. S Jung, HC Lee, JM Han, et al. (2002) Four cases of hepatitis B virus-related fibrosing cholestatic hepatitis treated with lamivudine. J Gastroenterol Hepatol 17 345-350.
50. KM Walsh, T Woodall, P Lamy, et al. (2001) Successful treatment with adefovir dipivoxil in a patient with fibrosing cholestatic hepatitis and lamivudine resistant hepatitis B virus. Gut 49 436-440.
51. E Munoz De Bustillo, C Ibarrola, F Colina, et al. (1998) Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant recipients. J Am Soc Nephrol 9 1109-1113.
52. CM Toth, M Pascual, RT Chung, et al. (1998) Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: Response to interferon-alpha therapy. Transplantation 66 1254-1258.
53. KG Benner, RG Lee, EB Keefe, et al. (1992) Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology 103 1307-1312.
54. JN Boletis, JK Delladetsima, F Makris, et al. (2000) Cholestatic syndromes in renal transplant recipients with HCV infection. Transpl Int 13(Suppl 1), S375-S379.
55. F Bonino and MR Brunetto (1994) Possible immunopathogenesis for fibrosing cholestatic hepatitis. Gastroenterology 106 822-823.
56. CH Chen, PJ Chen, JS Chu, et al. (1994) Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation. Gastroenterology 107 1514-1518.
57. PW Lam, ME Wachs, KA Somberg, et al. (1996) Fibrosing cholestatic hepatitis in renal transplant recipients. Transplantation 61 378-381.
58. H Zylberberg, F Carnot, MF Mamzer, et al. (1997) Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation. Transplantation 63 158-160.
59. NS Alshak, AM Jiminez, M Gedebou, et al. (1993) Epstein-Barr virus infection in liver transplantation patients: Correlation of histopathology and semiquantitative Epstein-Barr virus-DNA recovery using polymerase chain reaction. Hum Pathol 24 1306-1312.
60. AN Langnas, RS Markin, M Inagaki, et al. (1994) Epstein-Barr virus hepatitis after liver transplantation. Am J Gastroenterol 89 1066-1070.
61. PA Sheiner, E Mor, ME Schwartz and CM Miller (1993) Use of hepatitis C-positive donors in liver transplantation. Transplant Proc 25 3071.
62. TL Wright (1993) Liver transplantation for chronic hepatitis C viral infection. Gastroenterol Clin North Am 22 231-242.
63. JA Fishman, RH Rubin, MJ Koziel and BJ Periera (1996) Hepatitis C virus and organ transplantation. Transplantation 62 147-154.
64. BA Bouthot, BV Murthy, CH Schmid, et al. (1997) Long-term follow-up of hepatitis C virus infection among organ transplant recipients: Implications for policies on organ procurement. Transplantation 63 849-853.
65. M Salizzoni, F Lupo, F Zamboni, et al. (2001) Outcome of patients transplanted with liver from hepatitis C-positive donors. Transplant Proc 33 1507-1508.
66. G Testa, RM Goldstein, G Netto, et al. (1998) Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. Transplantation 65 925-929.
67. RM Ghobrial, R Steadman, J Gornbein, et al. (2001) A 10-year experience of liver transplantation for hepatitis C: Analysis of factors determining outcome in over 500 patients. Ann Surg 234 384-393. discussion 393–394
68. H Rodriguez-Luna, HG Vargas, P Sharma, et al. (2004) Hepatitis C virus recurrence in living donor liver transplant recipients. Dig Dis Sci 49 38-41.
69. H Van Vlierberghe, R Troisi, I Colle, et al. (2004) Hepatitis C infection-related liver disease: Patterns of recurrence and outcome in cadaveric and living-donor liver transplantation in adults. Transplantation 77 210-214.
70. PJ Gaglio, S Malireddy, BS Levitt, et al. (2003) Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors. Liver Transpl 9 1028-1035.
71. S Mukherjee, J Rogge, LK Weaver and DF Schafer (2003) Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation. Transplant Proc 35 3042-3044.
72. S Nair, S Khan, G Loss, et al. (2003) Treatment of recurrent hepatitis C in liver transplant recipients: Is there any histologic benefit? Liver Transpl 9 354-359.
73. C Feray, D Samuel, M Gigou, et al. (1995) An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejection. Hepatology 22 1084-1089.
74. AD Min and HC Bodenheimer Jr (1995) Does interferon precipitate rejection of liver allografts? Hepatology 22 1333-1335.
75. A Jain, AJ Demetris, R Manez, et al. (1998) Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon. Liver Transpl Surg 4 197-203.
76. S Saab, D Kalmaz, NA Gajjar, et al. (2004) Outcomes of acute rejection after interferon therapy in liver transplant recipients. Liver Transpl 10 859-867.
77. NA Terrault and G Vyas (2003) Hepatitis B immune globulin preparations and use in liver transplantation. Clin Liver Dis 7 537-550.
78. DM Anselmo, RM Ghobrial, LC Jung, et al. (2002) New era of liver transplantation for hepatitis B: A 17-year single-center experience. Ann Surg 235 611-619. discussion 619–620
79. Z Ben-Ari, E Mor and R Tur-Kaspa (2003) Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature. J Intern Med 253 544-552.
80. CJ Chu, RJ Fontana, C Moore, et al. (2001) Outcome of liver transplantation for hepatitis B: Report of a single center's experience. Liver Transpl 7 724-731.
81. D Seehofer, N Rayes, WO Bechstein, et al. (2000) [Treatment of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B-associated liver diseases.] Z Gastroenterol 38 773-783.
82. NA Terrault, S Zhou, RW McCory, et al. (1998) Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology 28 555-561.
83. HL Tillmann, C Trautwein, T Bock, et al. (1999) Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation. Hepatology 30 244-256.
84. TL Pruett and R McCory (2000) Hepatitis B immune globulin: ∼he US experience. Clin Transplant 14(Suppl 2), 7-13.
85. J Devlin, P Donaldson, B Portmann, et al. (1995) Recurrence of autoimmune hepatitis following liver transplantation. Liver Transpl Surg 1 162-165.
86. J Neuberger (1995) Recurrence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis. Liver Transpl Surg 1(5 Suppl 1), 109-115.
87. E Prados, V Cuervas-Mons, M de la Mata, et al. (1998) Outcome of autoimmune hepatitis after liver transplantation. Transplantation 66 1645-1650.
88. G Gotz, R Neuhaus, WO Bechstein, et al. (1999) Recurrence of autoimmune hepatitis after liver transplantation. Transplant Proc 31 430-431.
89. P Milkiewicz, SG Hubscher, G Skiba, et al. (1999) Recurrence of autoimmune hepatitis after liver transplantation. Transplantation 68 253-256.
90. V Ratziu, D Samuel, M Sebagh, et al. (1999) Long-term follow-up after liver transplantation for autoimmune hepatitis: Evidence of recurrence of primary disease. J Hepatol 30 131-141.
91. G Ayata, FD Gordon, WD Lewis, et al. (2000) Liver transplantation for autoimmune hepatitis: A long-term pathologic study. Hepatology 32 185-192.
92. A Vogel, E Heinrich, MJ Bahr, et al. (2004) Long-term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant 18 62-69.
93. J Neuberger (2002) Transplantation for autoimmune hepatitis. Semin Liver Dis 22 379-386.
94. SG Hubscher (2001) Recurrent autoimmune hepatitis after liver transplantation: Diagnostic criteria, risk factors, and outcome. Liver Transpl 7 285-291.
95. M Hayashi, EB Keefe, SM Krams, et al. (1998) Allograft rejection after liver transplantation for autoimmune liver diseases. Liver Transpl Surg 4 208-214.
96. S Narumi, K Hakamada, M Sasaki, et al. (1999) Liver transplantation for autoimmune hepatitis: Rejection and recurrence. Transplant Proc 31 1955-1956.
97. C Sempoux, Y Horsmans, J Lerut, et al. (1997) Acute lobular hepatitis as the first manifestation of recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver 17 311-315.
98. J Neuberger, B Portmann, R Calne and R Williams (1984) Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting. Transplantation 37 363-365.
99. HS Te, G Koukoulis and DR Ganger (1997) Autoimmune hepatitis: A histological variant associated with prominent centrilobular necrosis. Gut 41 269-271.
100. N Bach, SN Thung and F Schaffner (1992) The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis. Hepatology 15 572-577.
101. PB Sylvestre, KP Batts, LJ Burgart, et al. (2003) Recurrence of primary biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history. Liver Transpl 9 1086-1093.
102. J Neuberger, B Portmann, BR Macdougall, et al. (1982) Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med 306 1-4.
103. GA Weaver, WA Franck and WF Streck (1982) Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med 306 1235-1236.
104. AJ Demetris, BH Markus, C Esquivel, et al. (1988) Pathologic analysis of liver transplantation for primary biliary cirrhosis. Hepatology 8 939-947.
105. RJ Poison, B Portmann, J Neuberger, et al. (1989) Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Clinical and histologic follow-up studies. Gastroenterology 97 715-725.
106. V Balan, KB Batts, MK Porayko, et al. (1993) Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation. Hepatology 18 1392-1398.
107. SG Hubscher, E Elias, JA Buckels, et al. (1993) Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J Hepatol 18 173-184.
108. RF Liermann Garcia, C Evangelista Garcia, P McMaster and J Neuberger (2001) Transplantation for primary biliary cirrhosis: Retrospective analysis of 400 patients in a single center. Hepatology 33 22-27.
109. U Khettry, N Anand, PN Faul, et al. (2003) Liver transplantation for primary biliary cirrhosis: A long-term pathologic study. Liver Transpl 9 87-96.
110. BC Portmann (1999) Recurrence of primary biliary cirrhosis after transplantation. The pathologist's view. Eur J Gastroenterol Hepatol 11 633-637.
111. J Van de Water, LB Gerson, LD Ferrell, et al. (1996) Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. Hepatology 24 1079-1084.
112. M Sebagh, O Farges, L Dubel, et al. (1998) Histological features predictive of recurrence of primary biliary cirrhosis after liver transplantation. Transplantation 65 1328-1333.
113. JP Lerut, A Zimmermann and P Gertsch (1994) Late graft dysfunction after liver transplantation for primary biliary cirrhosis: Disease recurrence versus chronic graft rejection. Am J Gastroenterol 89 1896-1898.
114. T Kubota, A Thomson, AD Clouston, et al. (1999) Clinicopathologic findings of recurrent primary sclerosing cholangitis after orthotopic liver transplantation. J Hepatobiliary Pancreat Surg 6 377-381.
115. R Sheng, WL Campbell, AB Zajko and RL Baron (1996) Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: Evidence of recurrent disease. AJR Am J Roentgenol 166 1109-1113.
116. RF Harrison, MH Davies, JA Neuberger and SG Hubscher (1994) Fibrous and obliterative cholangitis in liver allografts: Evidence of recurrent primary sclerosing cholangitis? Hepatology 20 356-361.
117. H Liden, J Norrby, S Firman and M Olausson (2000) Liver transplantation for primary sclerosing cholangitis—a single-center experience. Transpl Int 13(Suppl 1), S162-S164.
118. IW Graziadei, RH Wiesner, KP Batts, et al. (1999) Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 29 1050-1056.
119. RM Rai, J Boitnott, AS Klein and PJ Thuluvath (2001) Features of recurrent primary sclerosing cholangitis in two consecutive liver allografts after liver transplantation. J Clin Gastroenterol 32 151-154.
120. RH Wiesner (2001) Liver transplantation for primary sclerosing cholangitis: Timing, outcome, impact of inflammatory bowel disease and recurrence of disease. Best Pract Res Clin Gastroenterol 15 667-680.
121. JA Goss, CR Shackleton, DG Farmer, et al. (1997) Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single-center experience. Ann Surg 225 472-481. discussion 481–483
122. A Vera, S Moledina, B Gunson, et al. (2002) Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. Lancet 360 1943-1944.
123. U Khettry, A Keaveny, A Goldar-Najafi, et al. (2003) Liver transplantation for primary sclerosing cholangitis: A long-term clinicopathologic study. Hum Pathol 34 1127-1136.
124. HR van Buuren, HJE van Hoogstraten, T Terkivatan, et al. (2000) High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J Hepatol 33 543-548.
125. DR Jeyarajah, GJ Netto, SP Lee, et al. (1998) Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: Is chronic rejection part of the disease process? Transplantation 66 1300-1306.
126. WR Kim, JJ Poterucha, MK Porayko, et al. (1996) Recurrence of nonalcoholic steatohepatitis following liver transplantation. Transplantation 62 1802-1805.
127. K Carson, MK Washington, WR Treem, et al. (1997) Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient. Liver Transpl Surg 3 174-176.
128. GW McCaughan (1997) Recurrence of nonalcoholic steatohepatitis (NASH) post-liver transplantation. Liver Transpl Surg 3 683.
129. RM Molloy, R Komorowski and RR Varma (1997) Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation. Liver Transpl Surg 3 177-178.
130. M Charlton, P Kasparova, S Weston, et al. (2001) Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl 7 608-614.
131. MJ Contos, W Cales, RK Sterling, et al. (2001) Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl 7 363-373.
132. A Sanjeevi, E Lyden, B Sunderman, et al. (2003) Outcomes of liver transplantation for cryptogenic cirrhosis: A single-center study of 71 patients. Transplant Proc 35 2977-2980.
133. EM Brunt (2002) Alcoholic and nonalcoholic steatohepatitis. Clin Liver Dis 6 399-420. vii
134. G Ayata, FD Gordon, WD Lewis, et al. (2002) Cryptogenic cirrhosis: Clinicopathologic findings at and after liver transplantation. Hum Pathol 33 1098-1104.
135. A Poonawala, SP Nair and PJ Thuluvath (2000) Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study. Hepatology 32 689-692.
136. J Ludwig, DB McGill and KD Lindor (1997) Review: Nonalcoholic steatohepatitis. J Gastroenterol Hepatol 12 398-403.
137. J Ludwig, TR Viggiano, DB McGill and BF Oh (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55 434-438.
138. BF Banner, L Savas, J Zivny, et al. (2000) Ubiquitin as a marker of cell injury in nonalcoholic steatohepatitis. Am J Clin Pathol 114 860-866.
139. EM Brunt (2001) Nonalcoholic steatohepatitis: Definition and pathology. Semin Liver Dis 21 3-16.
140. EM Brunt, CJ Janney, AM Di Bisceglie, et al. (1999) Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 94 2467-2474.